SGMO - Sangamo Therape Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (-0.99%) MITK (-0.42%) NVDA (-0.78%) TSLA (-1.74%) TVIX (4.54%) UGAZ (-2.16%) GRUB (5.14%) GH (-1.72%) GBT (-1.36%) FB (-1.96%) EXEL (1.93%) EXAS (-2.04%) ESV (-1.56%) EPZM (-12.11%) ECL (-0.01%) EA (-2.13%) DGAZ (2.19%) DE (-0.35%) CVS (1.02%) CVNA (-1.91%) CTRV (-7.67%) CHWY (0.86%) CGC (-1.98%) CALM (0.55%) BYND (6.82%)

SGMO - Sangamo Therapeutics

$9.73 0.17[1.68%]

15 mins delayed data

People also watch :

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$9.57	Open	$9.61
Volume	948.9K	Market Cap	1.09B
Yield		Last Dividend

Day

52 Week

Sangamo Announces Upcoming Presentation ...	06/21/19
BRISBANE, Calif. , June 21, 2019 /PRNewswire/ -- Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today announced the upcoming p...

Here’s What Hedge Funds Think About Sang...	06/19/19
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating...

Edited Transcript of SGMO earnings confe...	06/12/19
Q1 2019 Sangamo Therapeutics Inc Earnings Call

Denali's Hunter Syndrome Candidate G...	06/12/19
The FDA assigns an orphan drug designation and a rare pediatric disease designation to Denali's (DNLI) pipeline candidate, DNL310, for treating pa...

ANALYST RATINGS

0 analyst ratings (Last 6 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	2019-05-08 (AMC)	Est. (EPS/Rev.)	($0.25)/ 22.82M
Actual (EPS/Rev.)	$-0.41/ $8.07 M	EPS (TTM)	0

TRADERS TRACKING $SGMO

Service Name	Trader	% Success
Big Data Zhou	Zhou Academy	87.00 %	Subscribe
Write put options!	R. belegger	84.00 %	Subscribe

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%